AK

Ashwani Kumar

Active Director Director DIN 09241415
DIN 09241415 First appointment Jul 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Ashwani Kumar

Data last updated:

Ashwani Kumar is a Director at Reolab Healthcare Private Limited (since 2021) and Director at Rolson Pharmaceuticals Private Limited (since 2021). The companies operate in Chemicals.

DIN 09241415
Primary Designation Director
Industry Chemicals
First Appointment 15 Jul 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Reolab Healthcare Private Limited U24230RJ2021PTC077259
Director29 Sep 20212021Active
Director15 Jul 20212021Active

Board colleagues of Ashwani Kumar

Directorship timeline

Open interactive timeline →
Reolab Healthcare Private Limited
Rolson Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ashwani Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashwani Kumar

Ashwani Kumar currently holds 2 directorships: Reolab Healthcare Private Limited (Director, since 29 Sep 2021); Rolson Pharmaceuticals Private Limited (Director, since 15 Jul 2021).

Ashwani Kumar was first appointed on 15 Jul 2021 as Director at Rolson Pharmaceuticals Private Limited.

The current boards of Ashwani Kumar's companies include Arpit Arora (Reolab Healthcare Private Limited), Anurag Arora (Rolson Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available